The British government has confirmed plans to invest more than £63 billion ($84 billion) in its nuclear deterrent capabilities over the next four years. The announcement, made on June 30, forms part of a broader £15 billion ($20 billion) increase in defense spending introduced under the administration of outgoing Prime Minister Keir Starmer.

The funding package represents a major step in the United Kingdom’s ongoing efforts to modernize and expand its nuclear forces. It will support the development of Dreadnought-class ballistic missile submarines, SSN-AUKUS attack submarines, and the creation of a new domestically developed nuclear warhead known as Astraea.

This nuclear investment accounts for a substantial share of a wider four-year defense spending plan worth £298 billion ($398 billion). The strategy is designed to raise British defense expenditure to 2.7% of gross domestic product, with the longer-term objective of reaching NATO’s target of 3.5% by 2035.

The latest commitment continues a sustained increase in nuclear-related spending. During the 2024-25 fiscal year, the Ministry of Defence’s Defence Nuclear Enterprise consumed approximately £10.9 billion ($14.6 billion), equivalent to 18% of the defense budget. The Public Accounts Committee has projected that this proportion could eventually rise to 20% of overall military spending. Separately, the International Campaign to Abolish Nuclear Weapons estimated that Britain ranked as the world’s third-largest spender on nuclear weapons in 2025, allocating around $12.6 billion.

The scale of expenditure has drawn criticism from some domestic advocacy organizations, which contend that the resources could be better directed toward other national priorities. Government officials, however, maintain that the nuclear deterrent remains essential to safeguarding British sovereignty and emphasize the country’s unique role as Europe’s only nuclear power committed to using its deterrent capability in defense of NATO allies.

A key component of the modernization program is Astraea, designated as the A21/Mk7 warhead. Development of the system began in 2020 at the Atomic Weapons Establishment to replace the aging Holbrook warhead currently deployed on Trident II D5 missiles.

According to government officials and independent experts, replacing the Holbrook warhead is driven by operational necessity rather than political preference. Because British warheads must remain certified for compatibility with the American Mk4/Mk4A re-entry vehicle used by the U.S. Navy, the United Kingdom cannot continue extending the life of the existing Holbrook design once the United States transitions to its next-generation W93 warhead.

The British government has stated that Astraea is being developed alongside the American W93 program and will utilize the same Mk7 re-entry body. Analysis conducted by the U.K.-based nonprofit Nuclear Information Service, using publicly available data, suggests that Astraea’s explosive yield could range between 90 and 455 kilotons. If accurate, this would represent a significant increase over the estimated 80 to 100 kiloton yield of the current Holbrook warhead.

The latest announcement also reinforces Britain’s June 2025 decision to acquire 12 F-35A fighter aircraft and re-enter NATO’s Dual Capable Aircraft nuclear-sharing arrangement for the first time since the Cold War. Under this framework, U.S. B61-12 nuclear bombs are expected to be stationed in the United Kingdom and could be delivered by British aircraft if authorized by the U.S. president. Comparable nuclear-sharing arrangements already exist with the Netherlands, Belgium, Germany, Italy, and Turkey.

Britain’s nuclear modernization efforts are part of a broader global trend suggesting the possible emergence of a new era of nuclear rearmament after decades characterized by reductions, stagnation, and widespread public opposition following the Cold War.

In addition to Britain’s plans, France has expressed its intention to expand its nuclear arsenal and potentially extend its nuclear protection umbrella to other European nations, including the possible deployment of French nuclear-capable aircraft abroad.

China, meanwhile, continues to undertake a major expansion of its nuclear forces, raising concerns among policymakers in Washington.

At the same time, strategic arms control efforts between Russia and the United States—which together possess approximately 86% of the world’s nuclear weapons stockpile—have suffered a major setback, with the last remaining strategic arms reduction treaty having expired in February.